CICezary Iwaszkiewicz

Cezary Iwaszkiewicz

*This is an algorithmically generated author record based on publicly available information.

Cezary Iwaszkiewicz has a total of 8 co-authors. Here are the top co-authors by number of shared publications:

  • Mariusz Puszczewicz

    Department of Rheumatology, Rehabilitation and Internal Medicine, Poznan University of Medical Sciences, 61-545 Poznań, Poland

    2 shared publications
  • Piotr Leszczyński

    Katedra Reumatologii i Rehabilitacji Uniwersytetu Medycznego im. Karola Marcinkowskiego w Poznaniu; Oddział Reumatologii i Osteoporozy, Szpital im. Józefa Strusia w Poznaniu, ul. Szwajcarska 3, 61-285 Poznań, Poland

    2 shared publications
  • Piotr Leszczyński

    Department of Internal Medicine, Poznań University of Medical Sciences, Poznań, Poland

    2 shared publications
  • Bogdan Batko

    Department of Rheumatology and Immunology, Faculty of Medicine and Health Sciences, Andrzej Frycz Modrzewski University, Kraków, Poland

    1 shared publication
  • Brygida Kwiatkowska

    Clinic of Early Arthritis, National Institute of Geriatrics, Rheumatology and Rehabilitation, Warsaw, Poland

    1 shared publication
  • Grażyna Białkowska-Puszczewicz

    Department of Rheumatology and Internal Medicine; Poznan University of Medical Sciences; Poznań Poland

    1 shared publication

Latest Publications

  • Diagnosis and treatment of osteoporosis: 2026 recommendations of the Polish Society for Rheumatology

    by Piotr Leszczyński, Cezary Iwaszkiewicz, Zbigniew Michał Żuber, Brygida Kwiatkowska, Bogdan Piotr Batko, Katarzyna Krystyna Pawlak-Buś

    This publication presents the official recommendations of the Polish Society for Rheumatology for the diagnosis and treatment of osteoporosis. A panel of 6 experienced rheumatologists developed the document using an evidence-informed consensus process incorporating current evidence, clinical experience and the Polish healthcare context. Unanimous agreement was reached on all recommendations. The diagnostic section outlines the diagnostic criteria for osteoporosis in different patient groups and defines, for the first time, the role of radiofrequency echographic multi-spectrometry in clinical practice. The therapeutic section provides guidance on the optimal use of anti-osteoporotic drugs, including sequential therapy, and highlights the benefits of initiating treatment with an anabolic agent in patients at very high fracture risk. The document also addresses prevention of glucocorticoid-induced osteoporosis, osteoporosis in premenopausal women, and diagnosis and treatment in the paediatric population. These recommendations are intended to support early diagnosis and effective management of osteoporosis in Poland.


  • The Significance of Vitamin D in Adult Orthopaedics and Traumatology

    by Cezary Iwaszkiewicz, Piotr Leszczyński

    This review summarises the most recent data on the clinical significance of vitamin D in adult orthopaedics and traumatology. It covers practical aspects of vitamin D supplementation, along with their pathophysiological and epidemiological rationale. Special attention is given to the association between low vitamin D status and worse postoperative outcomes.


  • Bone densitometry by radiofrequency echographic multi-spectrometry (REMS) in the diagnosis of osteoporosis

    by Cezary Iwaszkiewicz, Piotr Leszczyński

    The paper summarises the present knowledge of the new bone densitometry method called radiofrequency echographic multi-spectrometry (REMS). This ultrasound-based approach enables the evaluation of bone mineral density (BMD) in the hip and the lumbar spine. During REMS densitometry, a fully automatic algorithm performs a series of spectral and statistical analyses involving both echographic images and corresponding “raw” (unfiltered) radiofrequency signals. This provides the identification of the region of interest (ROI) and the calculation of standard densitometric parameters: BMD, T-score and Z-score. Nondiagnostic scans and artifacts are automatically excluded by the algorithm, reducing the risk of false results. A recently published multi-center study has demonstrated high diagnostic sensitivity, specificity and accuracy of this innovative method in the diagnosis of osteoporosis. To the authors’ best knowledge, this is the first Polish paper on REMS densitometry. Forum Reumatol. 2019, tom 5, nr 2: 81–88 The paper summarises the present knowledge of the new bone densitometry method called radiofrequency echographic multi-spectrometry (REMS). This ultrasound-based approach enables the evaluation of bone mineral density (BMD) in the hip and the lumbar spine. During REMS densitometry, a fully automatic algorithm performs a series of spectral and statistical analyses involving both echographic images and corresponding “raw” (unfiltered) radiofrequency signals. This provides the identification of the region of interest (ROI) and the calculation of standard densitometric parameters: BMD, T-score and Z-score. Nondiagnostic scans and artifacts are automatically excluded by the algorithm, reducing the risk of false results. A recently published multi-center study has demonstrated high diagnostic sensitivity, specificity and accuracy of this innovative method in the diagnosis of osteoporosis. To the authors’ best knowledge, this is the first Polish paper on REMS densitometry. Forum Reumatol. 2019, tom 5, nr 2: 81–88


  • Serological markers in the diagnosis of rheumatoid arthritis — a clinician’s perspective

    by Cezary Iwaszkiewicz, Piotr Leszczyński

    The paper summarises the present knowledge of the role of autoantibodies in the diagnosis of rheumatoid arthritis. The starting point were the current rheumatoid arthritis classification criteria. The first part presents the diagnostic features of rheumatoid factor and anti-citrullinated protein/peptide antibodies, while the second part provides the answers to the essential clinical questions related to their use. This article, as opposed to more comprehensive papers in the field of immunology, focuses on daily rheumatological practice. Forum Reumatol. 2018, tom 4, nr 3: 169–177 The paper summarises the present knowledge of the role of autoantibodies in the diagnosis of rheumatoid arthritis. The starting point were the current rheumatoid arthritis classification criteria. The first part presents the diagnostic features of rheumatoid factor and anti-citrullinated protein/peptide antibodies, while the second part provides the answers to the essential clinical questions related to their use. This article, as opposed to more comprehensive papers in the field of immunology, focuses on daily rheumatological practice. Forum Reumatol. 2018, tom 4, nr 3: 169–177

  • Diagnostic value of the anti-Sa antibody compared with the anti-cyclic citrullinated peptide antibody in rheumatoid arthritis

    by Cezary Iwaszkiewicz, Mariusz Puszczewicz, Grażyna Białkowska-Puszczewicz

    To evaluate the prevalence and diagnostic significance of the autoantibody against citrullinated vimentin (anti‐Sa) compared with the widely used anti‐cyclic citrullinated peptide autoantibody (anti‐CCP) in patients with rheumatoid arthritis (RA).


  • Open Access

    Role of anti-citrullinated protein antibodies in diagnosis and prognosis of rheumatoid arthritis

    by Mariusz Puszczewicz, Cezary Iwaszkiewicz

    Antibodies to citrullinated proteins/peptides (ACPAs) are the second serological marker to have recently been included in the 2010 ACR/EULAR Rheumatoid Arthritis (RA) Classification Criteria, which are focused on early diagnosis and therapy. This review discusses their history and some clinical...